May 10, 2019

Genetic Technologies Completes Two Genetic Risk Tests for Colorectal and Breast Cancer

Genetic Technologies (NASDAQ:GENE, ASX:GTG), has announced two new cancer risk assessments, branded ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast...
February 1, 2019

Genetic Technologies Limited Announces Research Collaboration with Two Medical Centers

Genetic Technologies (NASDAQ:GENE,ASX:GTG) has announced a research agreement between its subsidiary, Phenogen, Memorial Sloan Kettering Cancer Center, New York and...
August 2, 2018

Genetic Technologies Formalises Strategic Alliance with Blockchain Global

Genetic Technologies (ASX:GTG; NASDAQ:GENE) has announced it has entered into a framework agreement with Blockchain Global Limited ACN 601 628...